Katz A E, Nysather J O, Harker L A
Ann Otol Rhinol Laryngol. 1978 May-Jun;87(3 Pt 1):412-5. doi: 10.1177/000348947808700323.
Serum immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM) levels were determined on 245 patients with carcinoma of the head and neck and on 92 controls. Ratios of these levels were calculated for each subject. The patients with cancer demonstrated elevated serum IgA levels (P less than .0001) and elevated IgA/IgM and IgA/IgG ratios (P less than .05). No differences were noted when the IgM/IgG ratios were compared between the cancer and the control groups. These observations are offered as evidence that previously reported elevations of serum IgA levels in patients with carcinoma of the head and neck are not merely an index of nonspecific increased immunoglobulin production in these patients.
对245例头颈部癌患者和92例对照者测定了血清免疫球蛋白A(IgA)、免疫球蛋白G(IgG)和免疫球蛋白M(IgM)水平。计算了每个受试者这些水平的比值。癌症患者血清IgA水平升高(P<0.0001),IgA/IgM和IgA/IgG比值升高(P<0.05)。比较癌症组和对照组的IgM/IgG比值时未发现差异。这些观察结果表明,先前报道的头颈部癌患者血清IgA水平升高不仅仅是这些患者非特异性免疫球蛋白产生增加的指标。